Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-15 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +2,812 43,989
2024-04-15 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −1,427 $11.89 $17K 42,562
2024-04-15 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise · Restricted Stock Units −2,812 8,439
2024-04-15 BILINSKY IGOR Chief Operating Officer Option exercise +2,812 39,453
2024-04-15 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −1,427 $11.89 $17K 38,026
2024-04-15 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −2,812 8,439
2024-03-04 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +15,623 49,230
2024-03-04 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −8,053 $16.96 $137K 41,177
2024-03-04 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise · Restricted Stock Units −15,623 31,252
2024-03-04 Vogt Frederick G Interim CEO & General Counsel Option exercise +41,662 140,800
2024-03-04 Vogt Frederick G Interim CEO & General Counsel Shares withheld for taxes −11,449 $16.96 $194K 129,351
2024-03-04 Vogt Frederick G Interim CEO & General Counsel Option exercise · Restricted Stock Units −41,662 83,338
2024-03-04 BILINSKY IGOR Chief Operating Officer Option exercise +14,061 43,928
2024-03-04 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −7,287 $16.96 $124K 36,641
2024-03-04 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −14,061 28,129
2024-03-01 YARNO WENDY L Director Grant or award · Deferred Restricted Stock Unit +25,000 25,000
2024-03-01 Rothbaum Wayne P. Director Grant or award · Deferred Restricted Stock Unit +100,000 100,000
2024-03-01 Vogt Frederick G Interim CEO & General Counsel Grant or award · Restricted Stock Units +500,000 500,000
2024-03-01 Vogt Frederick G Interim CEO & General Counsel Grant or award · Restricted Stock Units +93,750 93,750
2024-03-01 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +50,000 50,000

Page 15 of 23 · 446 trades